Apremilast

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1376 publications

Drug Development.

Drug Development.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 25, 2025

Erosive Oral Lichen Planus Treated With Upadacitinib Amid Systemic Psoriatic Therapy.

Erosive Oral Lichen Planus Treated With Upadacitinib Amid Systemic Psoriatic Therapy.

Journal: Cureus

Published: December 08, 2025

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study.

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study.

Journal: BMJ open

Published: November 12, 2025

Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report.

Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report.

Journal: Cureus

Published: November 11, 2025

Relative Efficacy of Immunomodulatory Monotherapies for Psoriasis of the Scalp: A Network Meta-Analysis Study.

Relative Efficacy of Immunomodulatory Monotherapies for Psoriasis of the Scalp: A Network Meta-Analysis Study.

Journal: Journal of cosmetic dermatology

Published: November 05, 2025

Apremilast Associated Clinical Improvement in Bullous Pemphigoid With Plaque Psoriasis.

Apremilast Associated Clinical Improvement in Bullous Pemphigoid With Plaque Psoriasis.

Journal: The Journal of dermatology

Published: October 23, 2025

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.

Journal: Dermatology and therapy

Published: October 16, 2025

Apremilast-mediated protection against Aβ-induced cytotoxicity correlates with PI3K/Akt pathway activation.

Apremilast-mediated protection against Aβ-induced cytotoxicity correlates with PI3K/Akt pathway activation.

Journal: Neuroscience

Published: October 07, 2025

The impact of apremilast on cardiometabolic and inflammation indexes in psoriatic patients at high cardiovascular risk: A real-world multicenter retrospective observational study.

The impact of apremilast on cardiometabolic and inflammation indexes in psoriatic patients at high cardiovascular risk: A real-world multicenter retrospective observational study.

Journal: Journal of the American Academy of Dermatology

Published: October 06, 2025

Oral lichen planus - an overview of aetiology and treatment

Oral lichen planus - an overview of aetiology and treatment

Journal: Therapeutische Umschau. Revue therapeutique

Published: October 01, 2025

Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial.

Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial.

Journal: Dermatology and therapy

Published: October 01, 2025

Apremilast attenuates hepatic steatosis and metabolic dysfunction in a murine model of MASLD: Implications for patients with Psoriatic disease.

Apremilast attenuates hepatic steatosis and metabolic dysfunction in a murine model of MASLD: Implications for patients with Psoriatic disease.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 27, 2025

Showing 1-12 of 1,376

Last Updated: 02/24/2026